Diagnostics Revolutions

Diagnostics Revolutions
  • Pininvest Analysis

By highlighting well respected companies providing systems for in-vitro diagnostics, including gene sequencing machines, and related services, we focus on advanced medical equipment used in clinical applications, in laboratories and in research.

The fastest growing areas, gene analysis techniques and splicing applied to fields of human identity testing, oncology research, infectious disease research, pharmacogenomics, and inherited disease boost research and product innovation in molecular biology (identifying potential drug targets), microbiology (defining how organisms evolve), medicine (tracking genetic diseases) and plant sciences

The breath of the applications with potential breakthrough in areas as diverse as healthcare, agriculture or environmental protection has opened vast opportunities for start-up companies applying the new technologies… but major uncertainties about commercial break-through leaves the potential investor exposed to extreme risk situations

To service the diagnostics market (evaluated at $ 60 billion and expected to continue to grow by 4% during the coming 5 years), manufacturers of the advanced medical equipment are placed on a strong footing

Diagnostics Revolutions • Updated:

Name Ticker Exchange Sector Industry Currency Cur.Price Mkt.Cap Perf. Vol. Risk Contrib. MDD
 
Accelerate Diagnostics AXDX NASDAQ Health Care Lab Analytical Instruments USD 7.75 437 M -46.9% 85%   6% -75%
Agilent Technologies A NYSE Health Care Medical Laboratories & Research USD 115.36 36 B 44.5% 36%   3% -30%
Bio-Rad Laboratories BIO NYSE Health Care Lab Analytical Instruments USD 557.28 17 B 49.9% 41%   3% -20%
Bio-Techne TECH NASDAQ Health Care Diagnostics USD 304.94 12 B 40.6% 38%   3% -27%
Bruker Corporation BRKR NASDAQ Health Care Lab Analytical Instruments USD 51.52 7.9 B 1.9% 49%   4% -41%
Cancer Genetics CGIX NASDAQ Health Care Diagnostics USD 2.50 5.8 M -65.8% 140%   5% -73%
Danaher DHR NYSE Conglomerates Industrial Conglomerates USD 225.00 160 B 54.9% 33%   3% -28%
Exact Sciences EXAS NASDAQ Health Care Diagnostics USD 123.23 19 B 52.2% 76%   5% -64%
Guardant Health GH NASDAQ Health Care Diagnostics USD 121.23 12 B 64.2% 61%   4% -34%
HTG Molecular Diagnostics HTGM NASDAQ Health Care Specialized Medical Devices USD 4.82 23 M -51.3% 88%   3% -67%
Illumina ILMN NASDAQ Health Care Gene Editing - Cell Therapies USD 334.34 49 B 4.6% 46%   4% -33%
Laboratory Corporation Of America LH NYSE Health Care Diagnostics USD 201.46 20 B 16.7% 52%   5% -47%
Lantheus Holdings LNTH NASDAQ Health Care Medical Consumables & Intermediates USD 13.46 899 M -33.6% 63%   5% -57%
NanoString Technologies NSTG NASDAQ Health Care Diagnostics USD 54.63 2.1 B 106.5% 81%   7% -56%
NeoGenomics NEO NASDAQ Health Care Gene Editing - Cell Therapies USD 47.09 5.2 B 83.2% 61%   5% -41%
OPKO Health OPK NASDAQ Health Care Diagnostics USD 4.27 2.9 B 173.7% 102%   6% -50%
Pacific Biosciences of California PACB NASDAQ Health Care Medical Technology USD 17.95 2.8 B 247.2% 78%   6% -58%
Perkinelmer PKI NYSE Health Care Lab Analytical Instruments USD 137.20 15 B 49.2% 37%   3% -34%
Quest Diagnostics Inc. DGX NYSE Health Care Diagnostics USD 125.68 17 B 20.1% 41%   3% -36%
Quidel Corp QDEL NASDAQ Health Care Diagnostics USD 188.95 7.9 B 178.6% 85%   4% -50%
Sonic Healthcare SKHHY OTC Health Care Diagnostics USD 24.22 - 21.8% 46%   3% -41%
Thermo Fisher Scientific TMO NYSE Health Care Lab Analytical Instruments USD 471.10 186 B 50.8% 37%   3% -17%
Veracyte VCYT NASDAQ Health Care Gene Editing - Cell Therapies USD 55.14 2.8 B 102.8% 70%   5% -47%
Waters WAT NYSE Health Care Lab Analytical Instruments USD 234.19 15 B 5.0% 40%   3% -33%